ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. It offers YourBiotixMH for menopause health; YourBiotixPMH for post-menopause health; YourBiotixCH for cholesterol maintenance; YourBiotixCH InstaMelt for cholesterol health; YourBiotixBP for blood pressure reduction; and YourBiotixVH for vascular health support. The company was formerly known as ProBiotix Health Limited and changed its name to ProBiotix Health Plc in February 2022. ProBiotix Health Plc was founded in 2012 and is based in Wakefield, the United Kingdom.
Metrics to compare | X90 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipX90PeersSector | |
---|---|---|---|---|
P/E Ratio | - | −5.2x | −0.5x | |
PEG Ratio | 5.63 | −0.05 | 0.00 | |
Price/Book | - | 2.2x | 2.6x | |
Price / LTM Sales | - | 13.4x | 3.3x | |
Upside (Analyst Target) | - | 112.6% | 45.4% | |
Fair Value Upside | Unlock | 0.1% | 7.7% | Unlock |